Neuronal mapping of the heart with 6-[18F]fluorometaraminol
Authors:
- Karen C. RosenspireKRKaren C. Rosenspire
- Gary D. HutchinsGHGary D. Hutchins
- Marcian Van DortMDMarcian Van Dort
- Jill M. RothleyJRJill M. Rothley
- Suresh G. MislankarSMSuresh G. Mislankar
- Helen T. LeeHLHelen T. Lee
- Christopher C. MassinCMChristopher C. Massin
- David L. GildersleeveDGDavid L. Gildersleeve
- 1 March 1990
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 33 (3) , 956-964
Abstract
The false neurotransmitter metaraminol labeled with fluorine-18 has been used to noninvasively assess regional adrenergic nerve density in the canine heart. Intravenous administration of 6-[18F]fluorometaraminol (FMR) results in high, selective accumulation of radioactivity in the heart; drug blocking studies with desipramine and reserpine confirm the neuronal locus of FMR. Iodine-125 labeled metaraminol, however, shows no selective accumulation in the canine heart. Positron emission tomography (PET) analyses with FMR of closed-chest dogs bearing left ventricular neuronal defects clearly delineate the region of neuronal impairment; blood perfusion in the left ventricle wall was homogeneous as determined by [13N]NH3 tomograms. The accumulation of FMR in regionally denervated dog heart correlates closely (r = 0.88) with endogenous norepinephrine concentrations. PET-generated 18F time-activity curves demonstrate marked kinetic differences between normal and denervated myocardium. FMR/PET analysis could be used to assess the heterogeneity of sympathetic innervation in human heart disease contingent on the development of FMR with sufficiently high specific activity to clearly avoid pressor activity.Keywords
This publication has 29 references indexed in Scilit:
- Distribution of metaraminol and its relation to norepinephrineEuropean Journal of Pharmacology, 1977
- Relationship between the uptake of 3H-(±) metaraminol and the density of adrenergic innervation in isolated rat tissuesNaunyn-Schmiedeberg's Archives of Pharmacology, 1977
- Radiopharmaceuticals. 16. Halogenated dopamine analogs. Synthesis and radiolabeling of 6-iododopamine and tissue distribution studies in animalsJournal of Medicinal Chemistry, 1976
- The Chemorelease of Norepinephrine in Mouse Hearts. Structure-Activity Relationships. II. Drugs Affecting the Sympathetic and Central Nervous SystemsJournal of Medicinal Chemistry, 1966
- THE INHIBITION OF NORADRENALINE UPTAKE BY SYMPATHOMIMETIC AMINES IN THE RAT ISOLATED HEARTBritish Journal of Pharmacology and Chemotherapy, 1965
- SUBCELLULAR DISTRIBUTION OF SOME SYMPATHOMIMETIC AMINES AND THEIR β-HYDROXYLATED DERIVATIVES IN THE RAT HEARTThe Journal of Pharmacology and Experimental Therapeutics, 1965
- BINDING AND RELEASE OF METARAMINOL: MECHANISM OF NOREPINEPHRINE DEPLETION BY α-METHYL-M-TYROSINE AND RELATED AGENTSThe Journal of Pharmacology and Experimental Therapeutics, 1964
- Release of Metaraminol (Aramine) from the Heart by Sympathetic Nerve StimulationScience, 1964
- EFFECT OF DRUGS ON THE UPTAKE AND METABOLISM OF H3-NOREPINEPHRINEThe Journal of Pharmacology and Experimental Therapeutics, 1961
- THE FATE OF H3-NOREPINEPHRINE IN ANIMALSThe Journal of Pharmacology and Experimental Therapeutics, 1961